Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glodent
- Development stage
- Unknown
- Lead developer
- Pharmaceuticals
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
Glodent is a whitening toothpaste developed by Group Pharmaceutical, primarily marketed in India. It utilizes a non-abrasive, enzymatic whitening mechanism featuring papain and bromelain, which are proteolytic enzymes derived from papaya and pineapple, respectively. These enzymes work by breaking down the protein pellicle on the tooth surface, which helps in removing extrinsic stains without damaging the enamel. The formulation also contains sodium monofluorophosphate to provide fluoride for enamel remineralization and caries prevention, as well as herbal extracts like Meswak and Neem for gum health maintenance.
- Brand names
- Glodent
02
Targets
HydroxyapatiteOral plaque bacteria
Beyond the preview
Go deeper on Glodent.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glodent.